Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
330 articles
Large Hong Kong registry study tracked how well patients stayed on newer JAK inhibitors versus traditional TNF blockers for RA treatment.
Risankizumab demonstrates effectiveness for Crohn's disease patients in multicenter Italian study across 47 medical centers.
Scientists identify key mechanism that determines why some immune thrombocytopenia patients maintain remission after stopping treatment.
Researchers develop standardized lung washing procedure that rapidly improves breathing and quality of life in patients with rare disease.
Revolutionary cancer treatment adapted for autoimmune diseases achieves drug-free remission in lupus trials, with RA applications emerging.
Researchers outline the scientific roadmap needed to cure autoimmunity without lifelong immunosuppressive drugs.
Local hormone system in joints fuels rheumatoid arthritis and osteoarthritis through distinct inflammatory pathways.
New study finds JAK inhibitors are as safe as other RA treatments for reproductive health in women of childbearing age.
New research reveals how vaccines delivered to mucosal surfaces create stronger, longer-lasting immunity than traditional shots.
New research reveals intermittent fasting forces immune memory cells from their protective niches, potentially compromising long-term immunity.
Researchers modified NK and T cells with special receptors that help them track down and infiltrate solid tumors more effectively.
New research reveals how helper T cells become highly destructive in joints, offering potential therapeutic targets for autoimmune arthritis.
